-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Today I continue to share career-related topics with my friends
What is the current state of the per capita productivity of our medical representatives, and now we have new data.
This data is based on the survey results of the sales of pharmaceuticals and the number of pharmaceutical representatives in each department in Japan published by the magazine.
There are five companies with pharmaceutical representatives with a per capita productivity of 200 million yen (approximately 11.
Per capita productivity of Japanese new drug companies (unit: million yen):
Per capita productivity of mature pharmaceutical companies in Japan (unit: million yen):
The survey also found that Japan’s overall drug sales fell year-on-year last year, and most companies are reducing the number of pharmaceutical representatives to maintain per capita productivity
Another company, Chugai Pharmaceutical, had sales of 409.
This is also true for the echelon where the per capita productivity of medical representatives is 200 million yen.
Astellas’ annual sales in Japan last year were 279.
So, let’s pay attention to it, whether in the pharmaceutical industry or in other industries, if the company’s revenue and profits decline, the company will give more consideration to single-person contributions.
Due to the large number of representatives in our country, the per capita productivity is a lot of several million yuan RMB.
In general, if you don't improve your ability, you may be eliminated
